Latest News & Features
Big Pharma
Johnson & Johnson has committed $500 million to research and development programmes over the next four years in a bid to eliminate HIV and tuberculosis across the world by 2030. 10 October 2019
Big Pharma
African drugmaker Aspen was able to increase its prices for fludrocortisone acetate tablets by 1,800% in the UK, as a result of collusion with two other firms, according to the UK’s Competition and Markets Authority. 9 October 2019
Americas
California has become the first US state to ban pay-for-delay deals in the pharmaceutical industry. 9 October 2019
Big Pharma
The English High Court has sided with pharmaceutical company Vectura and Novartis-owned Sandoz in a passing off lawsuit brought by rival GSK. 8 October 2019
Americas
The US Court of Appeals for the Federal Circuit last week reversed a Patent Trial and Appeal Board decision, which found that claims in an OSI Pharmaceuticals patent for cancer treatment were obvious. 7 October 2019
Big Pharma
A US subsidiary of Chinese genome sequencing company BGI has filed a patent infringement counterclaim against Illumina. 4 October 2019
Americas
LSX World Congress USA brings life sciences investment and partnering to Boston. 4 October 2019
Americas
Goldfinch Bio, a US company focused on developing treatments for kidney disease, has agreed to license a cannabinoid receptor 1 antibody from Japanese pharmaceutical manufacturer Takeda. 4 October 2019
Big Pharma
Novartis has teamed with Microsoft to launch a new artificial intelligence innovation lab, which it says has the potential to “transform” and “reimagine” medicine. 3 October 2019
Americas
The US Patent and Trademark Office (USPTO) has granted a new CRISPR-Cas9 patent to the University of California (UC), the University of Vienna and Emmanuelle Charpentier, marking the fifth consecutive week that the USPTO has approved a new patent in their CRISPR portfolio. 3 October 2019